Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Chronic Renal Failure Therapeutic Market Outlook

The global chronic renal failure therapeutic market size is expected to grow at a CAGR of 6% in the forecast period of 2024-2032. The industry has witnessed a substantial growth in the recent years across the world in both developing and developed countries.

Global Chronic Renal Failure Therapeutic Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Segmentation

Chronic kidney failure or chronic renal failure involves the loss of kidney functions over a prolonged period of time as opposed to acute renal failure. Stage 6 is for patients with a glomerular filtration rate of less than 15 mL per minute. For their renal failure, dialysis intervention is required.

Global Chronic Renal Failure Therapeutic Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF


 
The industry can be divided based on segments like the product types and regions. The industry can be broadly categorised on the basis of product into:

  • Antihypertensive Therapeutics
  • Antianaemia Therapeutics
  • Others

The EMR report looks into the regional markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

Global Chronic Renal Failure Therapeutic Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

Cardiovascular and metabolic conditions are the major risk factors for chronic renal failure. The increased prevalence of these risk factors leads to a significant increase in chronic renal disease incidence. Most of the market for this disorder is from the geriatric population in the United States, Europe, and Asia. Throughout the forecast period, the growing prevalence of chronic renal failure will consequently increase the growth prospects of the industry for chronic renal failure therapeutic. Developing novel inhibitors of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) will also accelerate the industry growth for chronic renal failure therapies. For patients without haemodialysis, oral administration of HIF-PH drugs is preferable. Such factors raise the demand for these medications, leading to the expansion of the global therapeutic market for chronic renal failure.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global chronic renal failure therapeutic market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Amgen Inc. (NASDAQ: AMGN)
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Pfizer Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Region
Breakup by Product
  • Antihypertensive therapeutics
  • Antianaemia Therapeutics
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach an
Companies Covered
  • Amgen Inc. 
  • AstraZeneca Plc
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The global chronic renal failure therapeutic market is projected to grow at a CAGR of 6% between 2023 and 2032.

The major drivers of the industry, such as the growing incidences of chronic renal failure, changing lifestyle and consumption patterns, increasing geriatric population, and the growing technological advancements, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the development of hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitors and the growing R&D activities.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Antihypertensive and antianaemia therapeutics, among others, are the leading products of chronic renal failure therapeutic in the industry.

The major players in the industry are Amgen Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Bayer AG, and Pfizer Inc., among others.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-120-433-0800

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124